Agilent | Drug Impurities

ARTICLE COLLECTION:
IMPURITIES IN PHARMACEUTICALS

Impurities in pharmaceuticals can drastically affect their efficacy and safety – even in very small quantities. Manufacturers must meet strict requirements for the purity and quality assurance of their products.

Download this free article collection to find application notes and recent research highlights on the development of LC-MS methods for the analysis of nitrosamines in pharmaceuticals and the analysis of other impurities.

This article collection contains:

Article on novel stability‐indicating high-performance liquid chromatography mass spectrometry (LC-MS) method
Article on method for the analysis of oligonucleotides
Article on reversed-phase HPLC method
Three recent studies on the quantification of various nitrosamines in pharmaceuticals
Agilent Case Studies

Register below to get access to the articles

Please send me a quote for the solutions highlighted in this eBook.

Yes

No

I would like to receive email updates about Agilent products, services, and events. For full details of how Agilent will treat your information please click here to view Agilent's privacy policy.

Yes, I have read and agree to Wiley’s Privacy Policy and Wiley’s Terms of Use. I understand my data may be shared with the sponsor of this article collection. *

Yes, Wiley may use my personal data for marketing and advertising purposes, including to contact me about Wiley’s products and services.

(*) These fields are mandatory. Without the provision of this data, accessing this article collection is not possible.

ARTICLE COLLECTION: IMPURITIES IN PHARMACEUTICALS

ARTICLE COLLECTION:
IMPURITIES IN PHARMACEUTICALS